๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmaceutical Technologies for Enhancing Oral Bioavailability of Poorly Soluble Drugs

โœ Scribed by S.R. Krishnaiah, Yellela

Book ID
119991458
Publisher
OMICS Publishing Group
Year
2010
Tongue
English
Weight
462 KB
Volume
02
Category
Article
ISSN
0975-0851

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Drug Delivery Strategies for Poorly Wate
Drug Delivery Strategies for Poorly Water-Soluble Drugs (Douroumis/Drug) || Development of Self-Emulsifying Drug Delivery Systems (SEDDS) for Oral Bioavailability Enhancement of Poorly Soluble Drugs
โœ Douroumis, Dennis; Fahr, Alfred ๐Ÿ“‚ Article ๐Ÿ“… 2013 ๐Ÿ› John Wiley & Sons Ltd ๐ŸŒ English โš– 447 KB

Many newly proposed drugs suffer from poor water solubility, thus presenting major hurdles in the design of suitable formulations for administration to patients. This work addresses the latest techniques and materials to overcome these hurdles, providing a thorough review of current formulation stra

[AAPS Advances in the Pharmaceutical Sci
[AAPS Advances in the Pharmaceutical Sciences Series] Formulating Poorly Water Soluble Drugs Volume 3 || Emerging Technologies to Increase the Bioavailability of Poorly Water-Soluble Drugs
โœ Williams III, Robert O.; Watts, Alan B.; Miller, Dave A. ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› Springer New York ๐ŸŒ English โš– 997 KB

This volume is intended to provide the reader with a breadth of understanding regarding the many challenges faced with the formulation of poorly water-soluble drugs as well as in-depth knowledge in the critical areas of development with these compounds. Further, this book is designed to provide prac

Enhancing the oral bioavailability of th
Enhancing the oral bioavailability of the poorly soluble drug dicumarol with a bioadhesive polymer
โœ Chris G. Thanos; Zhi Liu; Moses Goddard; Joshua Reineke; Nicola Bailey; Matthew ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 237 KB

This article investigates the effect of particle size and the incorporation of a bioadhesive polymer, poly(fumaric-co-sebacic) anhydride p(FA:SA), on the relative bioavailability of dicumarol. A novel method was used to reduce particle size of the drug, and encapsulated formulations were fabricated